<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">The Korea Centers for Disease Control and Prevention launched a national surveillance of enterovirus in 35 primary clinics, 105 secondary hospitals, and 40 tertiary hospitals nationwide since 1993. During 1999–2011, 4762 laboratory-confirmed enterovirus cases were recorded from the EV surveillance. Overall, around 15% of all positive samples were EV-A71, followed by echovirus 30 (13%) and CV-B5 (9%) [
 <xref ref-type="bibr" rid="CR73">73</xref>]. The first reported outbreak of EV-A71 in South Korea occurred in 2000, which involved 12 hospitalization cases [
 <xref ref-type="bibr" rid="CR73">73</xref>, 
 <xref ref-type="bibr" rid="CR74">74</xref>]. After an absence of 6 years, EV-A71 re-emerged and became endemic in South Korea with HFMD reported every year. An upsurge in severe HFMD disease in South Korea caused by EV-A71 occurred in 2009 beginning in the spring (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>) [
 <xref ref-type="bibr" rid="CR73">73</xref>]. Official records showed that there were 2427 cases, of which 94 cases of laboratory-confirmed EV-A71 infection involved complications of the CNS and 2 deaths [
 <xref ref-type="bibr" rid="CR2">2</xref>]. During this epidemic, the predominance of EV-A71 also co-incited with CV-A5 and CV-A6 circulation [
 <xref ref-type="bibr" rid="CR2">2</xref>].
</p>
